Device Trial Radar · NCT07794306
Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
510
Planned (sponsor's estimate)
Start
Oct 26, 2026
Primary completion
Jul 31, 2028
Study completion Dec 31, 2033
Sponsor
- Lead sponsor
- Universitätsklinikum Hamburg-EppendorfAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 31, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In Europe TAVI is now recommended for treatment of aortic valve stenosis from the age of 70 years. When performing TAVI in young patients, lifetime management becomes important in terms of anticipated TAVI-in-TAVI procedures when valve deterioration occures. Especially small aortic annuli represent a special challenge in terms of postprocedural hemodynamics, however intra-annular transcatheter heart valve designs should be the devices of choice to facilitate future TAVI-in-TAVI procedures. Which intra-annular valve design offers ideal clinical and hemodynamic efficacy is unclear. Therefore, an investigator-initiated, randomized controlled trial (BALANCE trial: Balloon- vs. Self-expanding intraannular TAVI in small aortic annuli) was created to elucidate this topic.
Conditions
- Aortic Valve Stenosis
Interventions
Meril Octapro+ THV SystemDevice
TAVI treatment with Meril Octapro+ THV System
Abbott Navitor/Navitor Vision THV systemDevice
TAVI treatment with Abbott Navitor/Navitor Vision System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Early Safety according to VARC-3 CriteriaTime frame: 30 Days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Medical Center Hamburg-Eppendorf (UKE), University Heart and Vascular Center Hamburg
Hamburg, Free and Hanseatic City of Hamburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.